CY1126031T1 - Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων - Google Patents

Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων

Info

Publication number
CY1126031T1
CY1126031T1 CY20231100253T CY231100253T CY1126031T1 CY 1126031 T1 CY1126031 T1 CY 1126031T1 CY 20231100253 T CY20231100253 T CY 20231100253T CY 231100253 T CY231100253 T CY 231100253T CY 1126031 T1 CY1126031 T1 CY 1126031T1
Authority
CY
Cyprus
Prior art keywords
compositions
gastrointestinal disorders
cleansing
colon
treatment
Prior art date
Application number
CY20231100253T
Other languages
Greek (el)
English (en)
Inventor
Mark G. Currie
Robert SOLINGA
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals, Inc. filed Critical Ironwood Pharmaceuticals, Inc.
Publication of CY1126031T1 publication Critical patent/CY1126031T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CY20231100253T 2015-05-01 2023-05-26 Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων CY1126031T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
CY1126031T1 true CY1126031T1 (el) 2023-11-15

Family

ID=55953439

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20231100253T CY1126031T1 (el) 2015-05-01 2023-05-26 Συνθεσεις για καθαρισμο του παχεος εντερου και την αντιμετωπιση γαστρεντερικων διαταραχων

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP4218789A3 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR20250042844A (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA3172777A1 (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10618938B2 (en) * 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders
SI3464336T1 (sl) 2016-06-01 2022-06-30 Athira Pharma, Inc. Spojine
CA3238634A1 (en) * 2021-11-24 2023-06-01 Christopher Leitheiser Synthetic process for production of modified gcc receptor agonists
WO2023097210A1 (en) * 2021-11-24 2023-06-01 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain
WO2026050206A1 (en) * 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
BR122018074353B8 (pt) * 2003-01-28 2023-05-02 Ironwood Pharmaceuticals Inc composição farmacêutica, polipeptídeo e métodos para a produção dos mesmos
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
EP1940441A4 (en) * 2005-08-19 2010-01-27 Ironwood Pharmaceuticals Inc COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
US20110172126A1 (en) * 2008-09-03 2011-07-14 Xenome Ltd Libraries of peptide conjugates and methods for making them
CA2790213A1 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
MX357121B (es) * 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) * 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
PL3004138T3 (pl) * 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie
WO2016015055A1 (en) 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
US10618938B2 (en) 2015-05-01 2020-04-14 Ironwood Pharmaceuticals, Inc. Compositions for colon cleansing and the treatment of gastrointestinal disorders

Also Published As

Publication number Publication date
MD3288578T2 (ro) 2023-08-31
RS64160B1 (sr) 2023-05-31
SMT202300114T1 (it) 2023-05-12
US10618938B2 (en) 2020-04-14
JP7862355B2 (ja) 2026-05-19
CN114716514A (zh) 2022-07-08
FI3288578T3 (fi) 2023-05-03
EP3288578A1 (en) 2018-03-07
EP3288578B8 (en) 2023-03-29
US20180148476A1 (en) 2018-05-31
EP3288578B1 (en) 2023-03-15
JP2025169325A (ja) 2025-11-12
EP4218789A2 (en) 2023-08-02
MA41985B1 (fr) 2023-04-28
CA2984437A1 (en) 2016-11-10
EP4218789A3 (en) 2023-09-27
CN108040482B (zh) 2022-03-29
PT3288578T (pt) 2023-03-28
WO2016178979A1 (en) 2016-11-10
LT3288578T (lt) 2023-04-25
CA3172777A1 (en) 2016-11-10
KR20250042844A (ko) 2025-03-27
ES2947591T3 (es) 2023-08-11
CA2984437C (en) 2025-11-18
JP2018519254A (ja) 2018-07-19
MX2022013283A (es) 2022-12-13
JP2024015335A (ja) 2024-02-01
JP2020203954A (ja) 2020-12-24
DK3288578T5 (da) 2024-10-07
SI3288578T1 (sl) 2023-07-31
KR20180005675A (ko) 2018-01-16
KR102783759B1 (ko) 2025-03-21
CN108040482A (zh) 2018-05-15
JP2022121734A (ja) 2022-08-19
DK3288578T3 (da) 2023-05-01
HUE061954T2 (hu) 2023-09-28
JP6930919B2 (ja) 2021-09-01
HRP20230381T1 (hr) 2023-07-07
PL3288578T3 (pl) 2023-08-14
EA201792401A1 (ru) 2018-05-31
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
US20240199697A1 (en) 2024-06-20
BR112017023539A2 (pt) 2018-08-14

Similar Documents

Publication Publication Date Title
CY1123746T1 (el) Ανθρωποποιημενα tau αντισωματα σε νοσο του alzheimer
CY1124959T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1124568T1 (el) Φαρμακευτικες συνθεσεις για την αγωγη παθησεων μεσολαβουμενων απο ρυθμιστη διαμεμβρανικης αγωγιμοτητας κυστικης ινωσης
CY1124918T1 (el) Ρυθμιστες ccr2
CY1125245T1 (el) Ετεροκυκλικες ενωσεις ως αναστολεις ρι3κ-γαμμα
CY1124055T1 (el) Ετεροκυκλικες ενωσεις ως ανοσοδιαμορφωτες
CY1122966T1 (el) 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου
CY1124729T1 (el) Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου
CY1125150T1 (el) Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου
CY1125127T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
CY1121550T1 (el) Ενωσεις πυριδινης πλαδιενολιδης και μεθοδοι χρησης
CY1123581T1 (el) Νεες μεθοδοι για την παραγωγη ολιγονουκλεοτιδιων
CY1120729T1 (el) Πεπτιδια και συνθεσεις για τη θεραπεια τραυματισμου των αρθρωσεων
CY1121360T1 (el) Αναστολεις dna-pk
CY1120361T1 (el) Αναστολεις 2,3-διοξυγενασης ινδολαμινης (ido)
EA201890325A1 (ru) Пептидные ингибиторы рецептора интерлейкина-23 и их применение для лечения воспалительных заболеваний
CY1118695T1 (el) Αναστολεις απομεθυλασων ιστονων
EA201290322A1 (ru) Лечение желудочно-кишечных расстройств
CY1122818T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-αλκυλ-8-αμινο-2-οξο-1,3-διαζα- σπε1ρο-[4.5]-δεκανιου
CY1121480T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν δοτες νιτροξυλιου
EA201692091A1 (ru) Хиноксалиновые соединения и их применение
EA201990400A1 (ru) Соединения и композиции и их применение
MX2022013283A (es) Composiciones para limpieza de colon y tratamiento de trastornos gastrointestinales.
EA201991196A1 (ru) Претерпевшие самосборку диблок-сополимеры, состоящие из pegmema и несущих лекарственное средство полимерных сегментов
CY1122923T1 (el) Παραγωγα 3-((ετερο-)αρυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου